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Abstract
Purpose: To compare the water-drinking test (WDT) and pharmacologic mydriasis as provocative tests in
patients with primary angle closure suspect (PACS).
Methods: This observational non-randomized comparative study evaluated changes in intraocular pressure
(IOP) in 21 patients with PACS who underwent pharmacologic mydriasis and compared it with IOP changes
in 26 patients given the WDT. Ocular biometric and anterior chamber parameters were also assessed. Tests
were repeated on the same patient two weeks after performing laser peripheral iridotomy (LPI).
Results: The mean age ± standard deviation was 60 ± 7 and 57 ± 9 years in the mydriasis andWDT groups,
respectively (P = 0.201). Before LPI, both provocative tests were associated with a significant increase in IOP
(mydriasis: 15.1± 3.1 to 16.6± 3.5mmHg, P = 0.025; WDT: 16.2± 2.8 to 18.5± 3.3 mmHg, P < 0.001). However,
the IOP changes were not statistically different between groups (P = 0.102). After LPI, only the WDT group
showed a continued significant IOP elevation after the test (mydriasis: 16.4 ± 3.3 to 16.7 ± 3.5 mmHg, P =
0.569; WDT: 14.9 ± 3.0 to 17.8 ± 4.1 mmHg, P < 0.001). The post-test IOP change was significantly greater
in the WDT than in the mydriasis group (3.0 versus 0.3 mmHg, respectively; P = 0.002). Step-wise multiple
regression analysis verified the type of provocative test as the only independent factor affecting the post-test
IOP change after LPI (regression coefficient: 2.664; P = 0.002).
Conclusion: Pharmacologic mydriasis and the WDT had similar IOP elevation before LPI, but after LPI, IOP
elevation was much greater in the WDT group.
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Primary angle closure glaucoma (PACG) is
believed to be one of the leading causes of
irreversible blindness with approximately 20
million people experiencing PACG worldwide.[1–3]
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The spectrum of angle closure disease includes
a narrow angle with 180° or more of iridotra-
becular apposition (primary angle closure suspect
[PACS]), a narrow angle with increased intraocular
pressure (IOP) or peripheral anterior synechiae
(primary angle closure, [PAC]), and PAC with optic
neuropathy or PACG.[4] It has been reported that
approximately 10% of PACS patients eventually
develop glaucoma.[2] While there is some evidence
that a prophylactic laser peripheral iridotomy (LPI)
significantly reduces the risk of angle closure
glaucoma in the contralateral eye of an individ-
ual with angle closure glaucoma, there is much
confusion regarding the need for a prophylactic
LPI for patients with asymptomatic narrow angles
detected through gonioscopy. Although LPI is an
effective preventive therapy, we must consider
the large number of candidates involved and the
burden and cost of treating ten-folds for each
eye that receives an actual benefit. Therefore,
identifying PACS eyes that would benefit from LPI
through appropriate imaging or provocative tests
is desirable. Various provocative tests including
the dark-room provocative test and pharmacologic
mydriasis have been used to identify narrow angle
eyes at risk of angle closure.[5] Pharmacologic or
dark-induced mydriasis leads to a relative pupillary
block and increased iridotrabecular contact. The
prone position in the dark room test may induce
forward movement of the lens and enhance the
effect of the relative pupillary block.[6] However,
this provocative test has a low sensitivity and pos-
itive predictive value in detecting eyes susceptible
to angle closure glaucoma.[7] Therefore, we need
to identify more appropriate provocative tests to
determine PACS patients with the greatest risk of
PACG and learn more about the mechanism of
angle closure formation.
The water-drinking test (WDT) is used as a
provocative test for assessing the outflow facility
of aqueous humor in patients with primary open-
angle glaucoma. Choroidal expansion is a sug-
gested mechanism of IOP elevation in WDT.[8, 9]
Choroidal expansion has also been suggested
as one of the mechanisms involved in PACG
development.[10] The expansion of the choroid after
WDT could push the iris-lens diaphragm forward
and result in a decrease in anterior chamber
volume.[8, 11] Therefore, this test has the potential to
be a provocative test in PACS. This study aimed to
evaluate the changes in the IOP, ocular biometric,
and anterior chamber parameters in PACS patients
who underwent WDT or pharmacologic mydriasis,
before and after LPI.
METHODS
This observational non-randomized comparative
study enrolled 47 consecutive patients with PACS
who were referred to the glaucoma clinic of a ter-
tiary eye care center. The first 21 referred patients
received the pharmacologic mydriasis test and the
next 26 patients underwent WDT. All procedures
performed in this study were in accordance with
the 1964 Helsinki Declaration and its later amend-
ments. The study was approved by the local Ethics
Committee and informed consent was obtained
from all patients. The patients underwent a com-
prehensive ophthalmologic examination including
slit lamp biomicroscopy, Goldmann applanation
tonometry (Haag Streit AG, Bern, Switzerland),
indentation gonioscopy using a Sussman 4-mirror
gonio lens (Volk Optical Inc., Mentor, OH, USA),
and stereoscopic assessment of the optic disc with
a 90 diopter lens (Volk Optical Inc., Mentor, OH,
USA). Subjects were classified as PACS if they
presented ≥ 180𝑜 of iridotrabecular contact, with-
out peripheral anterior synechiae in indentation
gonioscopy, glaucomatous optic neuropathy, or
IOP > 22 mmHg.[12] The exclusion criteria consisted
of a history of ocular trauma, prior intraocular or
refractive surgery, any intraocular disorder except
cataract, secondary angle closure glaucoma, evi-
dence of active keratitis or cornel pathology pre-
cluding gonioscopy and fundus examination, and
the use of miotics or anticholinergics, pregnancy,
hypertension, cardiac or kidney diseases, history of
urinary retention, or inability to cooperate with any
of the study measurements.
Water-drinking Test (WDT)
To perform the WDT, the patients refrained from
food and fluid intake for three hours preceding the
test. Patients were instructed to drink one liter of
bottled water within five minutes. All WDTs were
performed between 12 to 2 pm. The original WDT
developed for primary open angle glaucomadetec-
tion and the majority of recent studies assessing
the effect of WDT on IOP fluctuation used one
liter of water for this purpose.[13–16] Therefore, we
opted to use one liter instead of the 10–15 mL/kg
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reported by other studies. Themeasurements were
obtained at baseline and at 30 minutes after
drinking the water.[8] The patients then underwent
LPI using a commercial ophthalmic Nd: YAG laser
system (Nidek YC-1800, Nidek Inc., Japan) one
week after the WDT. The laser parameters were
as follows: one pulse with a power of 4–6 mJ
performed approximately 30 minutes after apply-
ing one drop of 2% pilocarpine eye drops.[17] Two
weeks after LPI, all measurements were repeated
before and after 30 minutes of WDT.
Mydriasis Test
Themeasurements were obtained before and after
the induction of pharmacologic mydriasis. In order
to eliminate any possible effects of cycloplegic
agents on the ciliary muscles and lens position,
mydriasis was achieved with phenylephrine 5%
drops applied every five minutes for a total of
two applications. LPI was performed the week
following the mydriasis test. All measurements
were repeated before and after mydriasis, two
weeks after LPI.
Measurements
The main outcome measure was IOP change after
the tests. An increase in IOP of ≥ 6 mmHg from
baseline was considered a positive result on both
provocative tests.[18] Secondary outcomes were
refraction ocular biometric parameters obtained
using Lenstar LS 900 (Haag-Streit AG, Koeniz,
Switzerland) and Pentacam HR (Oculus, Wetzlar,
Germany) optical biometers. The following param-
eters were collected from the Lenstar biometer:
mean keratometry (Km), keratometric astigmatism
(Ka), central corneal thickness (CCT), axial length
(AL), and lens thickness (LT). The Pentacam HR
was used to obtain Km, central anterior chamber
depth (ACD; from the endothelium to the anterior
lens surface), anterior chamber volume, and inferior
anterior chamber angle. The following factors were
calculated from the Lenstar recordings: lens-axial
length factor [LAF = (LT/AL) × 10]; lens position (LP
= ACD + 0.5 × LT); and relative lens position [RLP
= (LP/AL) × 10]. Each instrument was calibrated at
the beginning of the study, and at regular intervals
afterward (as per manufacturer’s recommenda-
tions). All measurements were performed by the
same experienced investigator using the criteria
provided by the manufacturer of each device.
Statistical Analysis
IBM SPSS Statistics software version 21 (SPSS Inc.,
Chicago, IL) and MedCalc version 12.2.1 (Med-
Calc Software, Mariakerke, Belgium) were used
for statistical analyses. Data from one eye of
each patient, chosen at random, were included in
the analysis. Descriptive data were presented as
mean (± standard deviation). The normality of data
was assessed using the Kolmogorov-Smirnov test.
The paired-samples T-test (or its nonparametric
counterpart, the Wilcoxon-signed Rank test) was
used to compare data before and after each test.
The independent-sample T-test (or Mann-Whitney
U test) was used to compare post-test changes
between different groups. Linear regression anal-
ysis was used to evaluate the effects of different
parameters on the test results. A P-value of less
than 0.05 was considered statistically significant.
RESULTS
Data from 21 PACS patients in the pharmacologic
mydriasis group were compared with 26 patients
in the WDT group. Table 1 summarizes the baseline
characteristics of patients in each group. Before
LPI, both provocative tests were associated with a
significant IOP elevation (Table 2). IOP elevation in
the WDT group was almost twice of the mydriasis
group (2.4 versus 1.3); however, the difference
was not statistically significant. Following LPI, the
WDT group had a significant increase in IOP after
the test, while the pharmacologic mydriasis group
did not [Table 2; Figure 1]. The post-LPI WDT
IOP-change was significantly greater in the WDT
than the mydriasis group (3.0 versus 0.3 mmHg,
respectively; P = 0.002). Before LPI, two (7.6%)
patients in the WDT and one (4.7%) in the mydriasis
group had positive test results (≥ 6 mmHg increase
in IOP), but after LPI, seven (26.9%) patients in
the WDT group and none of the patients in the
mydriasis group had positive test results (𝑃 = 0.01;
Chi-Square test).
There were no significant differences in biomet-
ric parameters for both tests before and after LPI
(data not shown). Because the two studied groups
were not similar in terms of sex and refraction, we
conducted a linear regression analysis to assess
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Table 1. Baseline characteristics of patients suspected of primary angle closure that underwent provocative testing with either
the pharmacologic mydriasis or water-drinking test
Provocative test Pharmacologic mydriasis Water-drinking test P-value
Number 21 26
Age, years 60 ± 7 57 ± 9 0.201
Sex, M/F 4/17 22/4 < 0.001
Spherical equivalent of refraction, D 1.3 ± 1.2 0.6 ± 1.0 0.036
Axial length, mm 22.5 ± 0.6 22.4 ± 0.8 0.731
Anterior chamber depth, mm 2.20 ± 0.21 2.24 ± 0.24 0.579
Anterior chamber volume, 𝜇m3 88.2 ± 13.7 94.3 ± 17.6 0.200
Anterior chamber angle, degrees 25.6 ± 7.0 28.2 ± 5.5 0.167
Central corneal thickness, 𝜇m 527 ± 35 535 ± 28 0.426
Mean keratometry, D 44.6 ± 1.2 44.7 ± 1.7 0.736
D, diopter; F, female; M, male; mm, millimeter; 𝜇m, micrometer
Table 2. Comparison of pharmacologic mydriasis and water-drinking tests as provocative tests in patients suspected of primary
angle closure before and after laser peripheral iridotomy
IOP (mmHg) before laser peripheral iridotomy
Before test After test P-value Changes*
Pharmacologic mydriasis 15.1 ± 3.1 16.6 ± 3.5 0.025 1.3 ± 2.2
Water-drinking Test 16.2 ± 2.8 18.5 ± 3.3 < 0.001 2.4 ± 2.1
P-value 0.102
IOP (mmHg) after laser peripheral iridotomy
Pharmacologic mydriasis 16.4 ± 3.3 16.7 ± 3.5 0.569 0.3 ± 2.5
Water-drinking test 14.9 ± 3.0 17.8 ± 4.1 < 0.001 3.0 ± 2.9
P-value 0.002
*Defined as: Post-test IOP – Pre-test IOP
IOP, intraocular pressure
the effects of different factors on the post-test IOP
changes after LPI (Table 3). In simple regression
analysis, sex, and the type of the provocative test
appeared to be associated with the observed post-
test IOP changes after LPI (P < 0.1). Figure 2 shows
the effects of sex on IOP changes after provocative
tests were performed before and after LPI. Sex
had no significant association with IOP changes
either before or after LPI (Mann-Whitney U test). In
line with this finding, step-wise multiple regression
analysis showed that the sex had no independent
effect, and the type of the provocative test was the
only independent factor affecting the post-test IOP
changes after LPI (regression coefficient: 2.664; P
= 0.002).
DISCUSSION
Our results showed that the amount of IOP eleva-
tion after pharmacologic mydriasis was less than
WDT-IOP elevation before and after LPI. There
was no statistically significant difference between
the pharmacologic mydriasis and WDT groups in
terms of IOP elevation before LPI, but after LPI, the
increase in IOPwas statistically significantly greater
in the WDT group. After LPI, the IOP changes
were lower in the mydriasis group compared with
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Table 3. Regression analysis of possible factors affecting IOP change after provocative tests of water-drinking test and pharma-
cologic mydriasis in patients with primary angle closure suspect after laser peripheral iridotomy




Test (WDT vs. pharmacologic mydriasis) 0.002* 2.664 0.002
Baseline IOP 0.225
SE Refraction 0.359
Anterior chamber depth 0.406
Anterior chamber volume 0.301
Anterior chamber angle 0.278
Axial Length 0.565
Central corneal thickness 0.814
Mean keratometry 0.118
*Factors with P-value less than 0.1 were entered into a multiple stepwise regression model
IOP, intraocular pressure; SE, spherical equivalent; WDT, water-drinking test
Figure 1. Comparison of intraocular pressure (IOP) changes
after the water-drinking test (WDT) and pharmacologic mydria-
sis in primary angle closure suspect patients before and after
laser peripheral iridotomy (LPI).
before LPI measurements, while the IOP changes
were greater in the WDT group in measurements
obtained after LPI than before LPI.
After LPI, the IOP changes in themydriasis group
were lower than before LPI (1.3 versus 0.3 mmHg),
while the differences were greater in the WDT
group (2.4 versus 3.00 mmHg). Moreover, there
was a greater number of patients with positive
WDT test results after LPI compared to before LPI.
The lower post-LPI IOP change in the mydriasis
group could be attributed to the resolution of the
pupillary block component of IOP elevation. A
higher change in WDT-IOP after LPI compared to
before LPI has been reported previously in PACS
patients.[19] The WDT-IOP elevation mechanisms
may not be dependent on the pupillary block, but
it is directly associated with the outflow capability
of aqueous humor. In a previous study, in 16 out of
18 eyes subjected to argon laser iridotomy, there
was evidence of decreased trabecular outflow after
LPI in tonography.[20] The decreased outflow may
be explained by the possibility of damage from
pigment release and inflammation after LPI to the
already somehow impaired trabecular meshwork
function due to the long-term apposition to the iris.
The WDT is a stress test that was initially devel-
oped to screen for open-angle glaucoma; however,
its diagnostic capabilities showed that the WDT
lacked the sensitivity and specificity needed to
be a reliable screening test. Currently, the WDT
is used to evaluate the aqueous outflow facility
and the efficacy of surgical and medical glaucoma
management, in addition to predicting the diurnal
IOP peak.[21, 22] Sympathetic stimulation via yet-to-
be-determined mechanisms has been suggested
to be responsible for the WDT-IOP elevation.[23]
Increased iris thickness, owing to sympathetic
J  O  V R Volume 14, Issue 3, July–September 2019 271
Water-drinking Test and Mydriasis in PACS; Razeghinejad and Nowroozzadeh
Figure 2. Effect of sex on intraocular pressure (IOP) changes after the water-drinking test (WDT) and pharmacologic mydriasis in
primary angle closure suspect patients before and after laser peripheral iridotomy (LPI).
stimulation of the iris dilatormuscle and its resulting
circumferential folding, may prompt angle closure
in patients with narrow angle glaucoma. Moreover,
a significant increase in choroidal thickness and
IOP elevation and a decrease in anterior chamber
depth after WDT have been observed in angle
closure but not in open angle eyes.[8] The lack of
any changes in the ocular biometric parameters in
our patients of both groups is in line with other
studies on the angle closure patients.[24–27] In a
group of fellow eyes of 21 patients with acute
primary angle closure and in 17 patients with PACG,
the ACD did not change following WDT.[26] The
study by Poon et al on PACG and primary open-
angle glaucoma revealed no association between
WDT-IOP changes and anterior chamber depth
and axial length.[25] In a study on patients with
PACS, PAC, and PACG, the positive dark room
and mydriasis tests were defined as an increase
in IOP of 6 mmHg. There was no difference in
the anterior chamber depth between positive and
negative testers (1.95 versus 1.89 mmHg, P = 0.3)
with the dark room test, but it was shallower in
the patients with a positive mydriasis test (1.77
versus 1.96 mmHg, P = 0.010). This difference
could have resulted from the limited number of
patients in each subgroup because the suggested
mechanisms underlying both tests are similar.[27] In
a study on PACS patients, no changes in ocular bio-
metric or anterior chamber parameters including
iridocorneal angle after peripheral iridotomy and/or
pharmacologic mydriasis except for increments in
anterior chamber volume were observed.[24]
The mechanisms involved in WDT-IOP elevation
are still unknown and may be different in open
and closed angle eyes. The resolution of the
pupillary block after LPI and the lower IOP elevation
observed following pharmacologic mydriasis and
the greater IOP elevation with WDT may exclude
the possibility of the pupillary block as the main
mechanism of WDT-IOP elevation in patients with
closed angle eyes. Long-term follow-up of patients
for IOP elevation may clarify the role of WDT in this
group of patients.
Although it has been suggested that LPI be
performed for narrow angles that fulfill the criteria
of PACS, the decision of which subjects require
prophylactic LPI remains highly subjective. It has
been estimated that approximately one out of ten
patients with anatomically narrow angles develop
angle closure,[28] therefore, the option of treating all
patients with narrow angles would result in a large
majority undergoing unnecessary procedures and
a waste of resources. There is a great demand to
develop a test that could identify PACS likely to
progress to PAC. It has been suggested that angle
closuremay often be caused by other mechanisms,
which would not be resolved by an iridotomy,
such as peripheral iris crowding, a plateau iris
or lens-related angle closure, and other unknown
mechanisms.[29] Interestingly, it has been reported
that the extent of PAS did not correlate with the
rise in IOP seen on provocative tests such as the
dark room test, pharmacologic mydriasis, and the
Valsalva test in patients with PAC.[18] Parameters
identifying eyes that continue to develop angle
closure after an iridotomy would lead to better
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management of PAC. Although LPI is claimed to
prevent PACS progression to PAC or PACG, it is
not guaranteed, as some patients progress despite
successful LPI. IOP elevation after WDT, but not
after pharmacologic mydriasis, probably involves
mechanisms other than pupillary block.
Limitations of our study include the relatively
small sample size; thus our results require vali-
dation in future studies involving more patients.
In addition, inherent variability of IOP measure-
ments because of diurnal changes and device
repeatability issues might affect the results. We
limited IOP measurements to the same time frame
on each day to minimize the confounding effects.
Another limitation is the lack of angle grading
information. Because the purpose of this study did
not include the evaluation of angles before and
after the LPI, we did not include the gonioscopy
grading. However, patients in both groups had
similar anterior chamber depth, anterior chamber
angle width, anterior chamber volume, and axial
length, which could indicate a lack of notable
differences in angle configuration between the
two groups. Performing pharmacologic mydriasis
before LPI may be regarded as an ethical limitation
of the current study as it may induce an acute
angle closure attack. None of the eyes in our study
developed an acute attack during the tests and the
IOPs prior to and following the LPI were very similar.
Diagnostic mydriasis appears to be relatively safe
in patients with narrow angle. The risk of acute
angle closure attack after pupillary dilation has
been reported to be 0.03–0.3%.[30, 31] Moreover,
in a study in the UK, 81% of ophthalmologists
doing provocative testing for PACS patients used
pupillary dilation and only 15% used the dark room
provocative test.[32] Nevertheless, we explained
the risks of the test to all patients. Finally, there was
a difference in the sex ratio between both groups,
but in the multiple regression analysis, the only
determinant factor affecting the IOP changes of the
provocative tests were the tests. Another limitation
could be the lack of long-term follow-up of the
patients and the correlation of the final glaucoma
status with the initial test results; however, conduct-
ing such a study would be difficult to execute.
In conclusion, both pharmacologicmydriasis and
WDT resulted in IOP elevation before LPI, but after
LPI the IOP elevationwas greater in theWDT group,
which could be explained by the resolution of the
pupillary block and consequently the lower IOP
elevation in the pharmacologic mydriasis group.
The mechanism of IOP elevation of WDT does
not seem to be related to the biometric changes
observed in PACS patients. Pharmacologic mydri-
asis and WDT may involve different mechanisms
for IOP elevation, which may have the potential to
advance our understanding about the mechanism
of angle-closure glaucoma.
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